MedTrace Logo

Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients

NCT01276483 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-06-22

No results posted yet for this study

Summary

The purpose of this study is to compare sensitivity, specificity and accuracy of PET, DW MRI and CT separately and combined for the evaluation of treatment response and progression-free survival in patients with GIST.

Conditions

  • Soft Tissue Neoplasms
  • Gastrointestinal Tract

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Mona-Elisabeth Revheim, MD · Oslo University Hospital, Dept of Nuclear Medicine

  • Therese Seierstad, PhD · Oslo University Hospital, Institute for Cancer Research

  • Øyvind S Bruland, Prof., MD · Oslo University Hospital, Dept of Oncology, The Norwegian Radium Hospital

  • Knut Håkon Hole, MD · Oslo University Hospital, Department of Diagnostic Radiology

  • Lars Julsrud, MD · Oslo University Hospital, Department of Diagnostic Radiology

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2017-06-30
Completion
2017-06-21

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01276483 on ClinicalTrials.gov